Dengue hemorrhagic fever in infants: Research opportunities ignored

Emerging Infectious Diseases

Volumn 8, Issue 12, 2002, Pages 1474-1479

  Halstead, Scott B ^a,g   Lan, Nguyen Trong ^b   Myint, Thein Thein ^c   Shwe, Than Nu ^c   Nisalak, Ananda ^d   Kalyanarooj, Siripen ^e   Nimmannitya, Suchitra ^e   Soegijanto, Soegeng ^f   Vaughn, David W ^d   Endy, Timothy P ^d  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Children's Hospital No 1   (Viet Nam)

^c Yangon Children Hospital   (Myanmar)

^d ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^e Queen Sirikit National Institute for Child Health   (Thailand)

^f AIRLANGGA UNIVERSITY   (Indonesia)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CAT DISEASE; DENGUE; DENGUE VIRUS; FELINE PANLEUKOPENIA VIRUS; HUMAN; INDONESIA; INFANT; MYANMAR; NONHUMAN; REVIEW; THAILAND; VIET NAM; VIRUS ISOLATION;

EID: 0036913768     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0812.020170     Document Type: Review

References (41)

1. Halstead SB. Pathogenesis of dengue: Challenges to molecular biology. Science 1988;239:476-81.
2. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181:2-9.
3. Ngo NT CX, Kneen R, Wills B, Nguyen VMN, Nguyen TQ, Chu VT, et al. Acute management of dengue shock syndrome: A randomized double-blind comparison of four intravenous fluid regimens in the first hour. Clin Infect Dis 2001;32:204-13.
4. Halstead SB, Nimmannitya S, Cohen SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 1970;42:311-28.
5. Halstead SB, Nimmannitya S, Yamarat C, Russell PK. Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Japanese Journal of Medical Science and Biology 1967;20:96-103.
6. Rothman AL, Ennis FA. Immunopathogenesis of dengue hemorrhagic fever. Virology 1999;257:1-6.
7. Halstead SB. Immunological parameters of Togavirus disease syndromes. In: Schlesinger RW, editor. The Togaviruses, Biology, Structure, Replication. New York: Academic Press; 1980. p. 107-73.
8. Kliks SC, Nimmannitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988;38:411-9.
9. Horzinek MC, Osterhaus AD. Feline infectious peritonitis: A coronavirus disease of cats. Small Anim Pract 1978;19:623-30.
10. Horzinek MC, Osterhaus AD. The virology and pathogenesis of feline infectious peritonitis: Brief review. Arch Virol 1979;59:1-15.
11. Weiss RC, Scott FW. Feline infectious peritonitis. In: Kirk RW, editor. Current Veterinary Therapy. Philadelphia: W.B. Saunders; 1980. p. 1288-92.
12. Vaughn DW, Green S, Kalayanrooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue in the early febrile phase: Viremia and antibody responses. J Infect Dis 1997;176:322-30.
13. Kuno G, Gomez I, Gubler DJ. An ELISA procedure for the diagnosis of dengue infections. J Virol Methods 1991;33:101-13.
14. Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis cocirculate. Am J Trop Med Hyg 1989;40:418-27.
15. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958;7:561-73.
16. World Health Organization. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. 2nd Edition. Geneva: The Organization; 1997.
17. Halstead SB, Scanlon J, Umpaivit P, Udomsakdi S. Dengue and chikungunya virus infection in man in Thailand, 1962-1964: IV. Epidemiologic studies in the Bangkok metropolitan area. Am J Trop Med Hyg 1969;18:997-1021.
18. Halstead SB. Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med 1970;42:350-62.
19. Fischer DB, Halstead SB. Observations related to pathogenesis of dengue hemorrhagic fever. V. Examination of age-specific sequential infection rates using a mathematical model. Yale J Biol Med 1970;42:329-49.
20. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 1989;40:444-51.
21. Weiss RC, Scott FW. Pathogenesis of feline infectious peritonitis: Nature and development of viremia. Am J Vet Res 1981;42:382-90.
22. Weiss RC, Scott FW. Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic fever. Comp Immunol Microbiol Infect Dis 1981;4:175-88.
23. Pederson NC, Boyle JF. Immunologic phenomena in the effusive form of feline infectious peritonitis. Am J Vet Res 1980;41:868-76.
24. Siddell SG. The Coronaviridae. In: Siddell SG, editor. The Coronaviridae. New York: Plenum Press; 1995.
25. Lai MMC. Recombination in large RNA viruses: Coronaviruses. Seminars in Virology 1996;7:381-8.
26. Herrewegh AA, Smeenk I, Horzinek MC, Rottier PJ, de Groot RJ. Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol 1998;72:4508-14.
27. Hohdatsu T, Tatekawa T, Koyama H. Enhancement of feline infectious peritonitis virus type I infection in cell cultures using low-speed centrifugation. J Virol Methods 1995;51:357-62.
28. Olsen CW. A review of feline infectious peritonitis virus: Molecular biology, immunopathogenesis, clinical aspects, and vaccination. Vet Microbiol 1993;36:1-37.
29. Hohdatsu T, Tokunaga J, Koyama H. The role of IgG subclass of mouse monoclonal antibodies in antibody-dependent enhancement of feline infectious peritonitis virus infection of feline macrophages. Arch Virol 1994;139:273-85.
30. Olsen CW, Corapi WV, Jacobson RH, Simkins RA, Saif LJ, Scott FW. Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity. J Gen Virol 1993;74:745-9.
31. Gollins SW, Porterfield JS. Flavivirus infection enhancement in macrophages: An electron microscopic study of viral cellular entry. J Gen Virol 1985;66:1969-82.
32. Mady BJ, Erbe DV, Kurane I, Fanger MW, Ennis FA. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc-gamma receptor. J Immunol 1991;147:3139-44.
33. Corapi WV, Olsen CW, Scott FW. Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J Virol 1992;66:6695-705.
34. Olsen CW, Corapi WV, Ngichabe CK, Baines JD, Scott FW. Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. J Virol 1992;66:956-65.
35. Pedersen NC. Animal virus infections that defy vaccination: Equine infectious anemia, caprine arthritis-encephalitis, maedi-visna, and feline infectious peritonitis. Adv Vet Sci Comp Med 1989;33:413-28.
36. Pedersen NC, Black JW. Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus. Am J Vet Res 1983;44:229-34.
37. Vennema H, DeGroot RJ, Harbour DA, Dalderup M, Gruffydd-Jones T, Horzinek MC, et al. Early death after feline infectious peritonitis challenge due to recombinant vaccinia virus immunization. J Virol 1990;64:1407-9.
38. Vennema H, DeGroot RJ, Harbour DA, Horzinek M, Spaan WJM. Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccine viruses in kittens. Virology 1991;181:327-35.
39. Chalmers WSK, Horsburgh BC, Baxendale W, Brown TDK. Enhancement of FIP in cats immunize with vaccina virus recombinants expressing CCV and TGEV spike glycoproteins. In: Laude H, Vautherot JF, editors. Coronoviruses. New York: Plenum Press; 1994. p. 359-64.
40. Watts DM, Porter KR, Putvatana P, Vasquez B, Calampa C, Hayes CG, et al. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever [see comments]. Lancet 1999;354:1431-4.
41. Kochel TJ, Watts DM, Halstead SB, Hayes CG, Espinosa A, Felices V, et al. Neutralization of American genotype dengue 2 viral infection by dengue 1 antibodies may have prevented dengue hemorrhagic fever in Iquitos, Peru. Lancet 2002;360:310-2.